Given the potential for emerging biomarkers to characterize the earliest detectable initiation of atherosclerotic disease (earlier than CRP, CAC, and CIMT), we assert that the construct of survivorship in CAD remains best defined as survival from time at initial biological atherosclerotic disease onset to time of coronary-related death. This evidence concerns the gene CRP and coronary artery disorder.